CN114366794A - Preparation method and application of traditional Chinese medicine and traditional Chinese medicine oral liquid for treating pelvic inflammation - Google Patents

Preparation method and application of traditional Chinese medicine and traditional Chinese medicine oral liquid for treating pelvic inflammation Download PDF

Info

Publication number
CN114366794A
CN114366794A CN202210046726.3A CN202210046726A CN114366794A CN 114366794 A CN114366794 A CN 114366794A CN 202210046726 A CN202210046726 A CN 202210046726A CN 114366794 A CN114366794 A CN 114366794A
Authority
CN
China
Prior art keywords
parts
fried
chinese medicine
traditional chinese
vinegar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210046726.3A
Other languages
Chinese (zh)
Inventor
吴泰蓉
孙而艺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhenjiang First Peoples Hospital
Original Assignee
Zhenjiang First Peoples Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhenjiang First Peoples Hospital filed Critical Zhenjiang First Peoples Hospital
Priority to CN202210046726.3A priority Critical patent/CN114366794A/en
Publication of CN114366794A publication Critical patent/CN114366794A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/483Gleditsia (locust)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • A61K36/575Magnolia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/744Gardenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/84Valerianaceae (Valerian family), e.g. valerian
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/86Violaceae (Violet family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/894Dioscoreaceae (Yam family)
    • A61K36/8945Dioscorea, e.g. yam, Chinese yam or water yam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994Coix (Job's tears)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/902Sparganiaceae (Bur-reed family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating pelvic inflammation, a preparation method and an application thereof, wherein the traditional Chinese medicine comprises the following components in parts by weight: 10-20 parts of sargentgloryvine stem, 10-20 parts of herba patriniae, 10-20 parts of poria cocos, 15-25 parts of semen coicis, 15-25 parts of bran-fried Chinese yam, 3-9 parts of angelica sinensis, 8-15 parts of fried bighead atractylodes rhizome, 8-15 parts of fried white peony root, 10-20 parts of radix rehmanniae, 10-20 parts of golden cypress, 10-20 parts of raw gardenia, 8-15 parts of Chinese violet, 5-15 parts of vinegar rhizoma sparganii, 10-20 parts of vinegar curcuma zedoary, 10-20 parts of spina gleditsiae, 10-20 parts of beautiful sweetgum fruit, 5-15 parts of radix sophorae flavescentis, 10-20 parts of fried scutellaria baicalensis, 5-15 parts of cortex magnoliae officinalis, 5-15 parts of fried green tangerine peel and 3-9 parts of liquorice, and the preparation method of the oral liquid comprises the following steps: soaking: soaking all the Chinese medicinal materials in water for 1 hr; mixing: drying the soaked traditional Chinese medicine components, and mixing all the dried components to obtain a mixture; boiling: adding the mixture into water, boiling with strong fire, decocting with slow fire for 40min, refluxing for 15min, cooling to room temperature, and filtering. The traditional Chinese medicine has good treatment effect and small side effect.

Description

Preparation method and application of traditional Chinese medicine and traditional Chinese medicine oral liquid for treating pelvic inflammation
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine for treating pelvic inflammation, a preparation method of a traditional Chinese medicine oral liquid and application of the traditional Chinese medicine oral liquid.
Background
Pelvic inflammation refers to chronic inflammation of female internal genitalia and its surrounding connective tissue, pelvic cavity and peritoneum, and is mainly manifested by menstrual disorder, leukorrhagia, lumbago and abdominal pain, infertility, etc. The disease is more frequent to married women of childbearing age, and in recent years, the incidence rate of pelvic inflammation is on the rise due to the influence of various factors such as the increase of birth control operations and the like, so that the disease becomes a common gynecological disease. The disease has the characteristics of long course of disease, stubborn state of illness, low cure rate, high recurrence rate and the like, and seriously harms the physical and mental health of women, so the pelvic inflammatory disease is effectively treated, the probability of developing diseases such as infertility, ectopic pregnancy or chronic pelvic pain is reduced, and the medicine has important significance for improving the life quality of women.
In the aspect of Western medicine, because antibiotics are applied for a long time to treat pelvic inflammation and abuse of antibacterial drugs, the symptoms of group flora imbalance, protracted duration and the like are easily caused, and the curative effect is not exact. The traditional Chinese medicine considers that the disease is weak, the uterus is not closed after menstruation and menstruation, healthy qi is not recovered, the body defense is not firm, cold, heat and damp evil qi enter while being deficient, the qi and the blood are in conflict with thoroughfare and conception vessels, the uterus is stagnated, the qi and the blood are consumed after repeated advancing and retreating, the deficiency and excess are mixed, the uterus is lingering and difficult to heal, and the heat is cleared away, the dampness is removed, the blood circulation is promoted, the blood stasis is dispersed, and the liver is soothed and the blood circulation is promoted in treatment. Therefore, it is considered that the treatment by the means of the traditional Chinese medicine through the body conditioning has less side effects and can obtain better treatment effect.
Disclosure of Invention
The invention aims to solve the technical problems and provides a traditional Chinese medicine for treating pelvic inflammation, a preparation method of a traditional Chinese medicine oral liquid and application of the traditional Chinese medicine oral liquid, which are used for treating pelvic inflammation on the principles of clearing heat and promoting diuresis, and promoting blood circulation and removing blood stasis, and have the advantages of good treatment effect and small side effect.
The traditional Chinese medicine for treating pelvic inflammation comprises the following components in parts by weight: 10-20 parts of sargentgloryvine stem, 10-20 parts of herba patriniae, 10-20 parts of poria cocos, 15-25 parts of semen coicis, 15-25 parts of bran-fried Chinese yam, 3-9 parts of angelica sinensis, 8-15 parts of fried bighead atractylodes rhizome, 8-15 parts of fried white peony root, 10-20 parts of radix rehmanniae, 10-20 parts of golden cypress, 10-20 parts of raw gardenia, 8-15 parts of Chinese violet, 5-15 parts of vinegar rhizoma sparganii, 10-20 parts of vinegar curcuma zedoary, 10-20 parts of spina gleditsiae, 10-20 parts of beautiful sweetgum fruit, 5-15 parts of radix sophorae flavescentis, 10-20 parts of fried scutellaria baicalensis, 5-15 parts of cortex magnoliae officinalis, 5-15 parts of fried green tangerine peel and 3-9 parts of liquorice.
Further, the composition comprises the following components in parts by weight: 12-18 parts of sargentgloryvine stem, 12-18 parts of herba patriniae, 12-18 parts of poria cocos, 17-23 parts of semen coicis, 17-23 parts of bran-fried Chinese yam, 5-7 parts of angelica sinensis, 10-14 parts of fried bighead atractylodes rhizome, 10-14 parts of fried white peony root, 12-18 parts of radix rehmanniae, 12-18 parts of golden cypress, 12-18 parts of raw gardenia, 10-14 parts of Chinese violet, 8-12 parts of vinegar rhizoma sparganii, 12-18 parts of vinegar curcuma zedoary, 12-18 parts of spina gleditsiae, 12-18 parts of beautiful sweetgum fruit, 8-12 parts of radix sophorae flavescentis, 12-18 parts of fried scutellaria baicalensis, 8-12 parts of cortex magnoliae officinalis, 8-12 parts of fried green tangerine peel and 5-7 parts of liquorice.
Further, the composition comprises the following components in parts by weight: 15 parts of sargentgloryvine stem, 15 parts of herba patriniae, 15 parts of poria cocos, 20 parts of semen coicis, 20 parts of bran-fried Chinese yam, 6 parts of angelica sinensis, 12 parts of fried bighead atractylodes rhizome, 12 parts of fried white peony root, 15 parts of radix rehmanniae, 15 parts of golden cypress, 15 parts of raw gardenia, 12 parts of Chinese violet, 10 parts of vinegar rhizoma sparganii, 15 parts of vinegar curcuma zedoary, 15 parts of spina gleditsiae, 15 parts of fructus liquidambaris, 10 parts of radix sophorae flavescentis, 15 parts of fried scutellaria baicalensis, 10 parts of ginger magnolia officinalis, 10 parts of fried green tangerine peel and 6 parts of liquorice.
Caulis Sargentodoxae is rattan or root of Schisandra sphenanthera or Schisandra sphenanthera of Magnoliaceae for clearing away heat and toxic materials; herba Patriniae (whole grass with root of Patrinia scabiosaefolia FISCH. of Patrinia of Patriniaceae) has no other peculiar smell when fresh, and has strong odor of odor sauce after sun drying, so it is named herba Patriniae, and can clear heat and remove toxic substances when used together with caulis Sargentodoxae; the poria cocos is dry sclerotia of the fungus poria cocos in the family of polyporaceae, collected in more than 7-9 months, removed of silt, piled up for sweating, spread and dried until the surface is dry, then sweated, and dried in the shade after wrinkles and most of internal water are dissipated repeatedly for a plurality of times, and is called as 'poria cocos pieces', or the fresh poria cocos is cut according to different parts and dried in the shade, and is called as 'poria cocos blocks' and 'poria cocos slices', and is used for treating edema and oliguria, phlegm and fluid retention and palpitation, poor appetite, loose stool and diarrhea, uneasiness, palpitation and insomnia; coix seed, dry mature seed kernel of coix seed of Gramineae, harvesting plants when fruit is mature in autumn, sun-drying, removing fruit, sun-drying, removing hull, tawny seed coat and impurities, collecting seed kernel, and can be used for treating edema, loempe, dysuresia, spleen deficiency diarrhea, damp arthralgia spasm, pulmonary abscess, appendicitis, wart, and cancer; the Chinese yam fried with bran has the effects of tonifying qi and yin, tonifying spleen and stomach, tonifying kidney and securing essence, and has the specific effects of nourishing, helping digestion, relieving cough, eliminating phlegm, desensitizing, reducing blood sugar and the like; angelica sinensis, a perennial herb, has the effects of enriching blood, promoting blood circulation, regulating menstruation, relieving pain, moistening dryness and lubricating intestines; the fried rhizoma atractylodis macrocephalae is a deficiency tonifying medicine and has the effects of strengthening spleen, replenishing qi and the like; parched radix Paeoniae alba, also called radix Paeoniae alba and JIAO NIAO, is a perennial herb of Paeonia of Ranunculaceae, and has effects of nourishing blood, regulating menstruation, and treating syndrome of liver qi disorder, blood and qi deficiency with symptoms of hypochondriac pain, dysphoria, menstrual abdominal pain, etc.; the rehmannia root, a perennial herb, is cool in nature and sweet and bitter in taste, and has the effects of nourishing yin, tonifying kidney, nourishing blood, enriching blood and cooling blood; cortex Phellodendri is dry bark of phellodendron chinense of Rutaceae, and has effects of clearing heat, eliminating dampness, clearing pathogenic fire, removing steam, removing toxic substance, and treating sore; fructus Gardeniae of Gardenia of Rubiaceae has effects of clearing heat, purging pathogenic fire, and relieving xerostomia; viola yedoensis makino is a perennial herb belonging to order of sidemembrane placentae, and Violaceae perennial root herb, is bitter, pungent and cold in taste, and has the functions of clearing heat and removing toxicity, cooling blood and relieving swelling, and clearing heat and promoting diuresis; the vinegar rhizoma Sparganii is a dry tuber, and has effects of removing blood stasis, activating qi-flowing, resolving food stagnation and relieving pain; the vinegar-processed Curcumae rhizoma is perennial herb of Curcuma of Zingiberaceae, and has effects in promoting qi circulation, resolving stagnation, removing blood stasis, and relieving pain; spina Gleditsiae is dried spina Gleditsiae of Leguminosae, and has effects of relieving swelling, removing toxic substance, expelling pus, and killing parasite; fructus Lipuidambaris is dry mature infructescence of Liquidambar formosana Hance of Hamamelidaceae, and has effects of dispelling pathogenic wind, activating collaterals, promoting diuresis, and dredging channels; radix Sophorae Flavescentis is the dry root of radix Sophorae Flavescentis of Leguminosae, and can be used for treating dysentery with fever, hematochezia, jaundice anuria, leucorrhea with red and white discharge, pudendal swelling and pruritus vulvae, eczema, skin pruritus, scabies, leprosy, and trichomonas vaginitis by external application; parched Scutellariae radix is perennial herb of Scutellariae radix of Labiatae, and can be used for treating epidemic febrile disease, upper respiratory infection, cough due to lung heat, damp-heat yellow gallbladder, pneumonia, dysentery, hemoptysis, conjunctival congestion, threatened abortion, hypertension, carbuncle, furuncle, sore, etc.; cortex Magnolia officinalis is bark or root bark of Magnoliaceae plant cortex Magnolia officinalis or cortex Magnolia officinalis, has bacteriophage resisting effect, and can inhibit tumor cells in vitro; the parched pericarpium Citri Reticulatae viride is pericarp of dried young fruit or immature fruit of Citrus reticulata Blanco of Rutaceae and its cultivar, and has effects of dispersing stagnated liver qi, relieving qi stagnation, and resolving food stagnation; the liquorice belongs to perennial herbs, has thick and strong root and rhizome, is a tonifying Chinese herbal medicine, and has the effects of clearing heat and removing toxicity, eliminating phlegm and relieving cough and epigastric and abdominal organs.
The traditional Chinese medicine formula is developed from the aspects of clearing heat, promoting diuresis, promoting blood circulation and removing blood stasis, the sargentgloryvine stem, the patrinia herb, the golden cypress, the raw gardenia, the philippine violet herb, the lightyellow sophora root, the fried baical skullcap root and the like have the effects of clearing heat and removing toxicity, the Chinese angelica, the vinegar rhizoma sparganii, the vinegar zedoary, the spina gleditsiae, the beautiful sweetgum fruit and the like have the effects of promoting blood circulation and removing meridian obstruction, the ginger officinal magnolia bark and the fried green skin have the effects of strengthening and activating spleen and stomach, regulating qi and eliminating dampness, and the poria cocos, the coix seed, the bran-fried Chinese yam, the fried largehead atractylodes rhizome, the fried white paeony root and the rehmannia root have the effects of protecting stomach qi, strengthening and activating spleen and soothing liver.
The traditional Chinese medicine formula disclosed by the invention has a better treatment effect on pelvic inflammation through the development of the component proportion.
A preparation method of a traditional Chinese medicine oral liquid for treating pelvic inflammation comprises the following steps:
soaking: soaking the above Chinese medicinal materials in water for 1 hr;
mixing: drying the soaked traditional Chinese medicine components, and mixing all the dried components to obtain a mixture;
boiling: adding the mixture into water, boiling with strong fire, decocting with slow fire for 40min, taking out, heating and refluxing for 15min, cooling to room temperature, and filtering to obtain Chinese medicinal oral liquid.
Further, in the soaking step, the solid-to-liquid ratio of the traditional Chinese medicine to the water is 1:2, and in the boiling step, the solid-to-liquid ratio of the mixture to the water is 1: 2.
Further, in the decocting step, a 300-mesh sieve is used for filtering.
An application of a traditional Chinese medicine for treating pelvic inflammation is disclosed.
Furthermore, the volume of each dose of the traditional Chinese medicine oral liquid is 100 ml.
Compared with the prior art, the invention has the following advantages and beneficial effects: the traditional Chinese medicine formula is developed from the aspects of clearing heat, promoting diuresis, promoting blood circulation and removing blood stasis, the sargentgloryvine stem, the patrinia herb, the phellodendron bark, the raw gardenia jasminoides, the philippine violet herb, the lightyellow sophora root, the fried baical skullcap root and the like have the effects of clearing heat and removing toxicity, the Chinese angelica, the vinegar rhizoma sparganii, the vinegar zedoary, the spina gleditsiae, the beautiful sweetgum fruit and the like have the effects of promoting blood circulation and removing meridian obstruction, the cortex magnoliae officinalis and the fried green skin have the effects of strengthening and transporting spleen and stomach, and the poria cocos, the coix seed, the bran-fried Chinese yam, the fried bighead atractylodes rhizome, the fried white paeony root and the dried rehmannia root have the effects of protecting stomach qi, strengthening and transporting spleen and soothing liver. In addition, it can also decompose hard mass, manage vital essence, promote blood circulation to remove blood stasis, relieve pain, clear away heat and toxic material, promote tissue softening, inhibit connective tissue hyperplasia, and maximally promote the functional recovery of hardened fallopian tube.
Drawings
The accompanying drawings, which are included to provide a further understanding of the embodiments and examples of the invention and are incorporated in and constitute a part of this application, illustrate embodiments and together with the description serve to explain the principles of the invention. In the drawings:
FIG. 1 is a B ultrasonic contrast chart before and after taking the traditional Chinese medicine of the invention by a patient with pelvic inflammation.
Detailed Description
The present invention will be further described with reference to the following examples. The following examples are only a few specific examples of the present invention, but the design concept of the present invention is not limited thereto, and any insubstantial modifications made by the design concept should fall within the scope of infringing on the protection scope of the present invention.
Example 1
The traditional Chinese medicine for treating pelvic inflammation comprises the following components in parts by weight: 10 parts of sargentgloryvine stem, 10 parts of herba patriniae, 10 parts of poria cocos, 15 parts of semen coicis, 15 parts of bran-fried Chinese yam, 3 parts of angelica sinensis, 8 parts of fried bighead atractylodes rhizome, 8 parts of fried white peony root, 10 parts of radix rehmanniae, 10 parts of golden cypress, 10 parts of raw gardenia, 8 parts of philippine violet herb, 5 parts of vinegar rhizoma sparganii, 10 parts of vinegar curcuma zedoary, 10 parts of spina gleditsiae, 10 parts of beautiful sweetgum fruit, 5 parts of radix sophorae flavescentis, 10 parts of fried scutellaria baicalensis, 5 parts of ginger-officinal magnolia bark, 5 parts of fried green tangerine peel and 3 parts of liquorice.
Example 2
The traditional Chinese medicine for treating pelvic inflammation comprises the following components in parts by weight: 20 parts of sargentgloryvine stem, 20 parts of herba patriniae, 20 parts of poria cocos, 25 parts of semen coicis, 25 parts of bran-fried Chinese yam, 9 parts of angelica sinensis, 15 parts of fried bighead atractylodes rhizome, 15 parts of fried white peony root, 20 parts of radix rehmanniae, 20 parts of golden cypress, 20 parts of raw gardenia, 15 parts of Chinese violet, 15 parts of vinegar rhizoma sparganii, 20 parts of vinegar curcuma zedoary, 20 parts of spina gleditsiae, 20 parts of fructus liquidambaris, 15 parts of radix sophorae flavescentis, 20 parts of fried scutellaria baicalensis, 15 parts of ginger magnolia officinalis, 15 parts of fried green tangerine peel and 9 parts of liquorice.
Example 3
The traditional Chinese medicine for treating pelvic inflammation comprises the following components in parts by weight: 15 parts of sargentgloryvine stem, 15 parts of herba patriniae, 15 parts of poria cocos, 20 parts of semen coicis, 20 parts of bran-fried Chinese yam, 6 parts of angelica sinensis, 12 parts of fried bighead atractylodes rhizome, 12 parts of fried white peony root, 15 parts of radix rehmanniae, 15 parts of golden cypress, 15 parts of raw gardenia, 12 parts of Chinese violet, 10 parts of vinegar rhizoma sparganii, 15 parts of vinegar curcuma zedoary, 15 parts of spina gleditsiae, 15 parts of fructus liquidambaris, 10 parts of radix sophorae flavescentis, 15 parts of fried scutellaria baicalensis, 10 parts of ginger magnolia officinalis, 10 parts of fried green tangerine peel and 6 parts of liquorice.
The above examples 1-3 can be prepared into a Chinese medicinal oral liquid by the following method, which comprises the following steps:
soaking: soaking all the Chinese medicinal materials in water for 1 hr;
mixing: drying the soaked traditional Chinese medicine components, and mixing all the dried components to obtain a mixture;
boiling: adding the mixture into water, boiling with strong fire, decocting with slow fire for 40min, taking out, heating and refluxing for 15min, cooling to room temperature, and filtering to obtain Chinese medicinal oral liquid.
More specifically, in the soaking step, the solid-to-liquid ratio of the traditional Chinese medicine to water is 1:2, and in the decocting step, the solid-to-liquid ratio of the mixture to water is 1: 2.
More specifically, in the decocting step, a 300-mesh sieve is used for filtering.
The traditional Chinese medicine is applied to the treatment of pelvic inflammation, and the volume of each dose of traditional Chinese medicine oral liquid is 100 ml.
Examples of the experiments
The experimental medicine is prepared by the method according to the component proportion in the example 3, and the traditional Chinese medicine oral liquid is obtained, wherein the dosage of each preparation is 100 ml.
The experimental object is selected from patients with pelvic inflammation sequelae symptoms, the age of the patients is 22-45 years old, the pelvic inflammation sequelae are not improved after the antibiotics are used, and the selected experimental object does not have interference indexes such as irregular menstruation (which is not caused by pelvic inflammation), dysmenorrheal, pelvic venous stasis syndrome, endometriosis, uterine adenomyoma, other reproductive organ diseases and the like.
The symptoms of the sequelae of the pelvic inflammation are generally as follows: menstrual disorder with leukorrhagia, accompanied by low fever, lower abdominal pain, lumbago, lower abdominal pain and lumbosacral pain, and symptoms may be aggravated by fatigue, sexual intercourse and defecation; the auxiliary medical examination is characterized in that: endometritis confirmed by endometrial biopsy or vaginal ultrasound examination, or MRI showing thickening and hydrops of the fallopian tube, the presence or absence of pelvic effusion and salpingo-ovarian mass or pelvic inflammatory symptoms found by laparoscopy, salpingitis existing on the signs, palpable cords on one or both sides of the uterus and mild tenderness associated with the symptoms, tenderness and tenderness on one or both sides of the uterus, and occlusive mass on one or both sides of the pelvic cavity.
The therapeutic effect evaluation standard of the experimental medicine is as follows:
and (3) curing: the clinical symptoms such as abdominal distension, swelling pain, lumbosacral pain and the like disappear after treatment; the results of gynecological examination and B-ultrasonic examination are recovered to normal.
The effect is shown: the clinical symptoms and physical signs of abdominal distension, swelling pain and lumbosacral pain after treatment are obviously relieved; the results of gynecological examination and B-ultrasonic examination showed slight abnormality
The method has the following advantages: the clinical symptoms and signs such as abdominal distension, swelling pain, lumbosacral pain and the like after treatment are relatively relieved; the results of gynecological examination and B-ultrasonic examination show that the disease condition is improved.
And (4) invalidation: the clinical symptoms and signs of abdominal distension, swelling pain and lumbosacral pain remain unchanged after treatment; the results of gynecological examination and B-ultrasonic examination were also unchanged.
The effective rate percentage is = (number of cured cases + number of cases with significant efficacy)/(number of cured cases + number of cases with significant efficacy + number of cases with no efficacy) × 100%.
The experiment selects 48 people of the experiment object, takes two doses of the traditional Chinese medicine oral liquid every day, one dose is taken in the morning and at night, 3 months are taken as a treatment course, 3 treatment courses are taken totally, after the administration is finished, the clinical symptoms of abdominal distension, swelling pain and lumbosacral pain are evaluated, physical signs are detected, gynecological examination and B-ultrasonic examination are carried out, and the results are shown in table 1:
TABLE 1 statistical table of the therapeutic effects of the oral liquid of the present invention
Cure of disease Has obvious curative effect Effective therapeutic effect Invalidation Total effective rate
Original prescription 9 12 17 2 95%
In conclusion, the traditional Chinese medicine has a good treatment effect on pelvic inflammation, the effective rate is as high as 95%, as shown in figure 1, after the patient is treated by the traditional Chinese medicine, B ultrasonic shows that the rigidity of connective tissues around the fallopian tube is relieved earlier, and the fallopian tube of the patient is dredged after the medicine is taken.
The above-mentioned embodiments are intended to illustrate the objects, technical solutions and advantages of the present invention in further detail, and it should be understood that the above-mentioned embodiments are merely exemplary embodiments of the present invention, and are not intended to limit the scope of the present invention, and any modifications, equivalent substitutions, improvements and the like made within the spirit and principle of the present invention should be included in the scope of the present invention.

Claims (8)

1. The traditional Chinese medicine for treating pelvic inflammation is characterized by comprising the following components in parts by weight: 10-20 parts of sargentgloryvine stem, 10-20 parts of herba patriniae, 10-20 parts of poria cocos, 15-25 parts of semen coicis, 15-25 parts of bran-fried Chinese yam, 3-9 parts of angelica sinensis, 8-15 parts of fried bighead atractylodes rhizome, 8-15 parts of fried white peony root, 10-20 parts of radix rehmanniae, 10-20 parts of golden cypress, 10-20 parts of raw gardenia, 8-15 parts of Chinese violet, 5-15 parts of vinegar rhizoma sparganii, 10-20 parts of vinegar curcuma zedoary, 10-20 parts of spina gleditsiae, 10-20 parts of beautiful sweetgum fruit, 5-15 parts of radix sophorae flavescentis, 10-20 parts of fried scutellaria baicalensis, 5-15 parts of cortex magnoliae officinalis, 5-15 parts of fried green tangerine peel and 3-9 parts of liquorice.
2. The traditional Chinese medicine for treating pelvic inflammation according to claim 1, which comprises the following components in parts by weight: 12-18 parts of sargentgloryvine stem, 12-18 parts of herba patriniae, 12-18 parts of poria cocos, 17-23 parts of semen coicis, 17-23 parts of bran-fried Chinese yam, 5-7 parts of angelica sinensis, 10-14 parts of fried bighead atractylodes rhizome, 10-14 parts of fried white peony root, 12-18 parts of radix rehmanniae, 12-18 parts of golden cypress, 12-18 parts of raw gardenia, 10-14 parts of Chinese violet, 8-12 parts of vinegar rhizoma sparganii, 12-18 parts of vinegar curcuma zedoary, 12-18 parts of spina gleditsiae, 12-18 parts of beautiful sweetgum fruit, 8-12 parts of radix sophorae flavescentis, 12-18 parts of fried scutellaria baicalensis, 8-12 parts of cortex magnoliae officinalis, 8-12 parts of fried green tangerine peel and 5-7 parts of liquorice.
3. The traditional Chinese medicine for treating pelvic inflammation according to claim 2, which comprises the following components in parts by weight: 15 parts of sargentgloryvine stem, 15 parts of herba patriniae, 15 parts of poria cocos, 20 parts of semen coicis, 20 parts of bran-fried Chinese yam, 6 parts of angelica sinensis, 12 parts of fried bighead atractylodes rhizome, 12 parts of fried white peony root, 15 parts of radix rehmanniae, 15 parts of golden cypress, 15 parts of raw gardenia, 12 parts of Chinese violet, 10 parts of vinegar rhizoma sparganii, 15 parts of vinegar curcuma zedoary, 15 parts of spina gleditsiae, 15 parts of fructus liquidambaris, 10 parts of radix sophorae flavescentis, 15 parts of fried scutellaria baicalensis, 10 parts of ginger magnolia officinalis, 10 parts of fried green tangerine peel and 6 parts of liquorice.
4. A method for preparing the oral liquid of the traditional Chinese medicine for treating the pelvic inflammatory disease according to any one of the claims 1 to 3, which is characterized by comprising the following steps:
soaking: soaking all the Chinese medicinal materials in water for 1 hr;
mixing: drying the soaked traditional Chinese medicine components, and mixing all the dried components to obtain a mixture;
boiling: adding the mixture into water, boiling with strong fire, decocting with slow fire for 40min, taking out, heating and refluxing for 15min, cooling to room temperature, and filtering to obtain Chinese medicinal oral liquid.
5. The preparation method of the traditional Chinese medicine according to claim 4, wherein in the soaking step, the solid-to-liquid ratio of the traditional Chinese medicine to water is 1:2, and in the decocting step, the solid-to-liquid ratio of the mixture to water is 1: 2.
6. The method for preparing the traditional Chinese medicine according to claim 4, wherein in the decocting step, a 300-mesh sieve is used for filtering.
7. The use of a Chinese medicinal composition according to any one of claims 1 to 3, wherein the Chinese medicinal composition is used for the treatment of pelvic inflammatory disease.
8. The use of the Chinese medicine according to claim 7, wherein the volume of each dose of the Chinese medicine oral liquid is 100 ml.
CN202210046726.3A 2022-01-17 2022-01-17 Preparation method and application of traditional Chinese medicine and traditional Chinese medicine oral liquid for treating pelvic inflammation Pending CN114366794A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210046726.3A CN114366794A (en) 2022-01-17 2022-01-17 Preparation method and application of traditional Chinese medicine and traditional Chinese medicine oral liquid for treating pelvic inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210046726.3A CN114366794A (en) 2022-01-17 2022-01-17 Preparation method and application of traditional Chinese medicine and traditional Chinese medicine oral liquid for treating pelvic inflammation

Publications (1)

Publication Number Publication Date
CN114366794A true CN114366794A (en) 2022-04-19

Family

ID=81187759

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210046726.3A Pending CN114366794A (en) 2022-01-17 2022-01-17 Preparation method and application of traditional Chinese medicine and traditional Chinese medicine oral liquid for treating pelvic inflammation

Country Status (1)

Country Link
CN (1) CN114366794A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101045152A (en) * 2006-03-30 2007-10-03 上海玉森新药开发有限公司 Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease concomitant inflammatory swelling
CN104758531A (en) * 2015-04-11 2015-07-08 成都市飞龙水处理技术研究所青白江第一分所 Medicine decoction for treating chronic pelvic inflammation and preparation method for medicine decoction
CN106177774A (en) * 2016-08-22 2016-12-07 张雷 A kind of medicine treating pelvic inflammatory disease

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101045152A (en) * 2006-03-30 2007-10-03 上海玉森新药开发有限公司 Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease concomitant inflammatory swelling
CN104758531A (en) * 2015-04-11 2015-07-08 成都市飞龙水处理技术研究所青白江第一分所 Medicine decoction for treating chronic pelvic inflammation and preparation method for medicine decoction
CN106177774A (en) * 2016-08-22 2016-12-07 张雷 A kind of medicine treating pelvic inflammatory disease

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘晶晶等: "清热解毒利湿法治疗慢性盆腔炎体会", 《辽宁中医药大学学报》 *
陈芸芸: "安盆汤治疗慢性盆腔炎临床观察", 《上海中医药杂志》 *

Similar Documents

Publication Publication Date Title
CN102872418B (en) Medicine for treating pelvic inflammation
CN1181858C (en) Chinese medicine composition for treating pile
CN108186863A (en) A kind of Chinese medicine for treating psoriasis
CN103446376A (en) Traditional Chinese medicine composition used for treating radiation proctitis
CN101361949B (en) Traditional Chinese medicine for treating gynaecologic emmeniopathy
CN105079726A (en) Medicine composition for treating hemorrhoids and preparation method thereof
CN104958448A (en) Medicine for treating puerperal infection
CN103432419A (en) Traditional Chinese medicinal composition for treating dysfunctional uterine bleeding and preparation method of preparation thereof
CN104998232A (en) Dysmenorrhea patch
CN104984265A (en) Traditional Chinese medicine preparation for cutaneous hemangioma and preparation method thereof
CN114366794A (en) Preparation method and application of traditional Chinese medicine and traditional Chinese medicine oral liquid for treating pelvic inflammation
CN115282229A (en) Traditional Chinese medicine composition for treating coronary heart disease with syndrome of qi deficiency and blood stasis and preparation method thereof
CN108619471B (en) Danhuang stasis removing capsule and preparation process thereof
CN102940821A (en) Traditional Chinese medicine for treating morbid leucorrhea of gynaecology
CN106214905A (en) A kind of Chinese medicine composition treating mastitis and preparation method thereof
CN105833123A (en) Chinese medicinal composition for treating venation diseases and preparation method thereof
CN110201075A (en) A kind of pharmaceutical composition for treating chalazion
CN104940828A (en) Traditional Chinese medicine composition for treating viral hepatitis and preparation method of traditional Chinese medicine composition
CN105343313A (en) Traditional Chinese medicinal composition for treating senile skin pruritus and preparation method of traditional Chinese medicinal composition
CN108671125A (en) A kind of Chinese medicine prescription for treating adenomyosis
CN104274555B (en) Traditional Chinese medicine composition for treating rheumatism, ointment and preparation method of traditional Chinese medicine composition
CN104971340B (en) A kind of Chinese medicine preparation and preparation method thereof for treating diarrhea associated with menstruation
CN110496199B (en) Medicine for treating psoriasis and preparation method thereof
CN105688158B (en) A kind of Chinese materia medica preparation and preparation method thereof for treating autoimmune liver disease
CN115721693A (en) A Chinese medicinal pill with multiple effects

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20220419